Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients

By Rieger Johannes   Bähr Oliver   Müller Klaus   Franz Kea   Steinbach Joachim   Hattingen Elke  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy

By Sasaki Makoto   Sugimoto Koichi   Masuda Azuchi   Tsukune Yutaka   Yahata Yuriko   Komatsu Norio  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 295-296

Springer Publishing Company

Access to resources Recommend Favorite

Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature

By Iwadate Yasuo   Suganami Akiko   Ikegami Shiro   Shinozaki Natsuki   Matsutani Tomoo   Tamura Yutaka   Saeki Naokatsu   Yamanaka Ryuya  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 261-268

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series

By Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 113, Iss. 1, 2013-05 ,pp. : 27-32

Springer Publishing Company

Access to resources Recommend Favorite

Ocular involvement in patients with primary CNS lymphoma

By Hong Jung   Chae Ju   Lee Joo   Kim June-Gone   Yoon Young  

Journal of Neuro-Oncology, Vol. 102, Iss. 1, 2011-03 ,pp. : 139-145

Springer Publishing Company

Access to resources Recommend Favorite